509 related articles for article (PubMed ID: 29356953)
21. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer.
Alyami M; Bonnot PE; Mercier F; Laplace N; Villeneuve L; Passot G; Bakrin N; Kepenekian V; Glehen O
Eur J Surg Oncol; 2021 Jan; 47(1):123-127. PubMed ID: 32561204
[TBL] [Abstract][Full Text] [Related]
22. Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group).
Wimberger P; Wehling M; Lehmann N; Kimmig R; Schmalfeldt B; Burges A; Harter P; Pfisterer J; du Bois A
Ann Surg Oncol; 2010 Jun; 17(6):1642-8. PubMed ID: 20165986
[TBL] [Abstract][Full Text] [Related]
23. Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Blanco A; Giger-Pabst U; Solass W; Zieren J; Reymond MA
Ann Surg Oncol; 2013 Jul; 20(7):2311-6. PubMed ID: 23377563
[TBL] [Abstract][Full Text] [Related]
24. Oncological Outcomes After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in the Treatment of Peritoneal Carcinomatosis.
Tidadini F; Abba J; Quesada JL; Trilling B; Bonne A; Foote A; Faucheron JL; Arvieux C
J Gastrointest Cancer; 2023 Jun; 54(2):632-641. PubMed ID: 35778645
[TBL] [Abstract][Full Text] [Related]
25. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.
Ellebæk SB; Graversen M; Detlefsen S; Lundell L; Fristrup CW; Pfeiffer P; Mortensen MB
Clin Exp Metastasis; 2020 Apr; 37(2):325-332. PubMed ID: 32002724
[TBL] [Abstract][Full Text] [Related]
26. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO).
du Bois A; Reuss A; Pujade-Lauraine E; Harter P; Ray-Coquard I; Pfisterer J
Cancer; 2009 Mar; 115(6):1234-44. PubMed ID: 19189349
[TBL] [Abstract][Full Text] [Related]
27. PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.
Bakrin N; Tempfer C; Scambia G; De Simone M; Gabriel B; Grischke EM; Rau B
Pleura Peritoneum; 2018 Sep; 3(3):20180114. PubMed ID: 30911662
[TBL] [Abstract][Full Text] [Related]
28. [Malignant epithelial ovarian cancer: Role of intra peritoneal chemotherapy and hyperthermic intra peritoneal chemotherapy (HIPEC): Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
Bakrin N; Gladieff L
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):214-221. PubMed ID: 30712963
[TBL] [Abstract][Full Text] [Related]
29. Pressurized Intraperitoneal Aerosol Chemotherapy with Cisplatin and Doxorubicin in Women with Peritoneal Carcinomatosis: A Cohort Study.
Tempfer CB; Rezniczek GA; Ende P; Solass W; Reymond MA
Anticancer Res; 2015 Dec; 35(12):6723-9. PubMed ID: 26637888
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of peritoneal carcinomatosis with pressurized intraperitoneal aerosol chemotherapy].
Graversen M; Pfeiffer P; Mortensen MB
Ugeskr Laeger; 2016 May; 178(21):. PubMed ID: 27237925
[TBL] [Abstract][Full Text] [Related]
31. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.
Esselen KM; Rodriguez N; Growdon W; Krasner C; Horowitz NS; Campos S
Gynecol Oncol; 2012 Oct; 127(1):51-4. PubMed ID: 22659193
[TBL] [Abstract][Full Text] [Related]
32. Pressurized intraperitoneal aerosol chemotherapy as an innovative approach to treat peritoneal carcinomatosis.
Tempfer CB
Med Hypotheses; 2015 Oct; 85(4):480-4. PubMed ID: 26277656
[TBL] [Abstract][Full Text] [Related]
33. Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study.
Tempfer CB; Winnekendonk G; Solass W; Horvat R; Giger-Pabst U; Zieren J; Rezniczek GA; Reymond MA
Gynecol Oncol; 2015 May; 137(2):223-8. PubMed ID: 25701703
[TBL] [Abstract][Full Text] [Related]
34. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Procedure for Non-resectable Peritoneal Carcinomatosis (with Video).
Cazauran JB; Alyami M; Lasseur A; Gybels I; Glehen O; Bakrin N
J Gastrointest Surg; 2018 Feb; 22(2):374-375. PubMed ID: 28900843
[TBL] [Abstract][Full Text] [Related]
35. Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
Barlin JN; Dao F; Bou Zgheib N; Ferguson SE; Sabbatini PJ; Hensley ML; Bell-McGuinn KM; Konner J; Tew WP; Aghajanian C; Chi DS
Gynecol Oncol; 2012 Jun; 125(3):621-4. PubMed ID: 22446622
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with gastric cancer and peritoneal metastasis.
Javanbakht M; Mashayekhi A; Branagan-Harris M; Horvath P; Königsrainer A; Reymond MA; Yaghoubi M
Eur J Surg Oncol; 2022 Jan; 48(1):188-196. PubMed ID: 34479745
[TBL] [Abstract][Full Text] [Related]
37. Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis.
Alyami M; Gagniere J; Sgarbura O; Cabelguenne D; Villeneuve L; Pezet D; Quenet F; Glehen O; Bakrin N; Passot G
Eur J Surg Oncol; 2017 Nov; 43(11):2178-2183. PubMed ID: 28964609
[TBL] [Abstract][Full Text] [Related]
38. Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Graversen M; Detlefsen S; Bjerregaard JK; Pfeiffer P; Mortensen MB
Clin Exp Metastasis; 2017 Jun; 34(5):309-314. PubMed ID: 28516306
[TBL] [Abstract][Full Text] [Related]
39. Nutritional status, cachexia, and anorexia in women with peritoneal metastasis and intraperitoneal chemotherapy: a longitudinal analysis.
Hilal Z; Rezniczek GA; Klenke R; Dogan A; Tempfer CB
J Gynecol Oncol; 2017 Nov; 28(6):e80. PubMed ID: 29027398
[TBL] [Abstract][Full Text] [Related]
40. Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review.
Ploug M; Graversen M; Pfeiffer P; Mortensen MB
BMC Cancer; 2020 Feb; 20(1):105. PubMed ID: 32041558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
